FDA snubs Novartis bid to repurpose inflammation drug canakinumab for heart attacks Medical Dialogues Bureau21 Oct 2018 10:01 AM ISTIn trials for heart disease, Novartis discovered a potential benefit in lung cancer patients for the drug, prompting the company to start cancer...
Takeda gets Japan's approval for $62 billion Shire purchase Medical Dialogues Bureau21 Oct 2018 9:27 AM ISTTakeda Pharmaceutical Co Ltd. said on Thursday Japan's Fair Trade Commission had approved its $62 billion acquisition of Shire Plc, bringing the...
Shire's drug Takhzyro for rare swelling disorder wins European panel green light Medical Dialogues Bureau21 Oct 2018 9:01 AM ISTA European Medicines Agency(EMA) panel on Friday recommended approving a potential blockbuster drug from Shire Plc to treat patients aged 12 and older...
Sanofi drug Dupixent wins USFDA approval to treat asthma Medical Dialogues Bureau20 Oct 2018 12:32 PM ISTFrance's Sanofi SA said on Friday eczema drug Dupixent was approved by the U.S. Food and Drug Administration as an additional maintenance therapy in...
Maryland asks Supreme Court to uphold law on drug pricing Medical Dialogues Bureau20 Oct 2018 12:32 PM ISTANNAPOLIS, Md.: Maryland Attorney General Brian Frosh petitioned the U.S. Supreme Court on Friday to uphold a first-in-the-nation law against...
Zydus Cadila gets USFDA nod for generic gout attacks drug- Colchicine Medical Dialogues Bureau20 Oct 2018 12:30 PM ISTThe tablets, "will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad," it said.New Delhi: Drug firm Zydus Cadila...
Novartis to buy cancer drugmaker Endocyte for $2.1 Billion in cash Medical Dialogues Bureau20 Oct 2018 9:18 AM ISTNovartis AG will acquire U.S. based cancer drugmaker Endocyte Inc for $2.1 billion in cash as the Swiss drugmaker expands its radio pharmaceuticals...
Zydus Cadila gets USFDA nod to market Clobetasol Propionate cream for skin treatment Medical Dialogues Bureau19 Oct 2018 10:51 AM ISTNew Delhi: Drug firm Zydus Cadila Wednesday said it has received final nod from the US health regulator to market generic Clobetasol Propionate cream,...
Samsung launches third rival to AbbVie's Humira drug in EU Medical Dialogues Bureau19 Oct 2018 9:20 AM ISTLONDON: South Korea's Samsung Bioepis and its partner Biogen have launched a third rival to AbbVie's blockbuster medicine Humira in Europe, ramping up...
FDA approves Pfizer drug for advanced breast cancer Medical Dialogues Bureau19 Oct 2018 9:20 AM ISTZurich: The U.S. Food and Drug Administration said on Tuesday it approved Pfizer Inc’s drug for an advanced form of breast cancer tied to an inherited...
Alembic Pharma gets USFDA nod for diabetes drug Alogliptin Medical Dialogues Bureau18 Oct 2018 12:12 PM ISTNew Delhi: Drug firm Alembic Pharmaceuticals Tuesday said it has received tentative nod from the US health regulator for its Alogliptin tablets used...
Multiple sclerosis drug: US court invalidates Teva's patent; boost for Natco, Mylan Medical Dialogues Bureau18 Oct 2018 11:50 AM ISTCopaxone is the most prescribed for relapsing forms of MS in the U.S., with brand sales for the 20 mg/ml dose at approximately $527 million and about...
